Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BATTLE study of inhaled tobramycin in non-cystic fibrosis bronchiectasis
2016-000166-35Phase 2Active
- Sponsor
- Noordwest Ziekenhuisgroep
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tobramycin in bronchiectasis (3 arms), sponsored by Noordwest Ziekenhuisgroep. Primary endpoint: Exacerbation rate reduction. Started May 2016; status: active.
02
Drugs
tobramycin
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on 2016-000166-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000166-35.